ANI Pharmaceuticals reported $65.36M in EBITDA for its fiscal quarter ending in December of 2025.





Ebitda Change Date
AbbVie USD 5.37B 1.85B Dec/2025
ANI Pharmaceuticals USD 65.36M 5.76M Dec/2025
Aurora Cannabis CAD 3.7M 14.78M Mar/2026
Canopy Growth CAD -137M 134.13M Mar/2026
Eli Lilly USD 12.14B 4.26B Dec/2025
Heron Therapeutics USD -3.88M 5.63M Sep/2024
Hikma Pharmaceutical USD 369M 84M Dec/2024
Knight Therapeutics CAD 24.45M 3.46M Dec/2025
Nektar Therapeutics USD -31.81M 70K Sep/2023
Novartis USD 5.41B 431M Mar/2026
Omeros USD -47.96M 7.39M Sep/2023
Perrigo USD 141.6M 1.34B Mar/2026
Sun Pharmaceuticals INR 39.54B 9.94B Mar/2026
Teva Pharmaceutical Industries USD 1.06B 582M Mar/2026